Kestra Medical Technologies, Ltd. (KMTS) earnings: date, estimates and history
Price $28.64 · data as of November 13, 2026
Next earnings report
Track record
Kestra Medical Technologies beat the consensus earnings estimate in 5 of its last 5 reports, by +25.0% on average. On report days the stock moved 7.8% on average, up or down.
Earnings history
| Reported | EPS estimate | EPS actual | Surprise | Revenue | Revenue growth | Stock move |
|---|---|---|---|---|---|---|
| September 14, 2026 Jul/2026 | $-0.62 | $-0.46 | +26.7% | $31M | +59.9% | +10.2% |
| July 14, 2026 Apr/2026 | $-0.58 | $-0.49 | +15.8% | $29M | +66.2% | −0.6% |
| March 17, 2026 Jan/2026 | $-0.60 | $-0.40 | +32.6% | $25M | +62.7% | +1.7% |
| December 11, 2025 Oct/2025 | $-0.56 | $-0.45 | +19.8% | $23M | +53.4% | +6.7% |
| September 11, 2025 Jul/2025 | $-0.66 | $-0.46 | +30.3% | $19M | +51.5% | +20.0% |
EPS as compared with analyst estimates (adjusted EPS). Revenue growth is against the same quarter a year earlier. Stock move: change on the first trading day after the report.
Frequently asked questions
When is Kestra Medical Technologies’s next earnings date?
Kestra Medical Technologies is expected to report on December 10, 2026 (quarter Oct/2026).
Did Kestra Medical Technologies beat earnings last quarter?
Yes, it reported EPS of $-0.46 on September 14, 2026 against an estimate of $-0.62 (a +26.7% surprise), and the stock moved +10.2% the next trading day.
What EPS do analysts expect next quarter?
The consensus estimate is $-0.61 per share on revenue of about $32M.
Report dates and estimates from analyst consensus data; results from company reports. Updated daily. Not investment advice. Earnings calendar